Grant brings NYBC scientists one step closer to developing a preventive vaccine ready for first-in-human trials by 2020

Two new studies provide an unprecedented look into the genome, transcriptome, and proteome of the river blindness parasite and its bacterial endosymbiont, Wolbachia

MERS, a severe respiratory illness with symptoms of fever, cough and shortness of breath, has a mortality rate of approximately 36 percent